Every owner asks the question in the same words, and most of the answers they find are either from another country or from someone who wants to buy the store. Here is the Canadian answer, with the numbers we work from, three worked examples, and what moves the figure up or down.
The short answer
In our experience, most Canadian community pharmacies sell for 4x to 6x normalized EBITDA, plus inventory at cost. The provincial baselines we start from run 4.5x to 7x, with most provinces centred between 5.25x and 6.25x, before adjustments for the size of the earnings base and for risk. Those baselines are published, by province, on our valuation page, and they are the same parameters the free calculator on that page runs on.
So the question “how much is my pharmacy worth” has two parts: what is your normalized EBITDA, and what multiple applies to it.
Part one: normalized EBITDA
EBITDA is earnings before interest, taxes, depreciation and amortization. Normalized EBITDA is that figure adjusted to show what the pharmacy earns for an owner who pays a market manager to run it:
- add back owner compensation above a market pharmacist manager salary (the calculator uses a provincial figure, for example $125,000 in BC and $130,000 in Alberta);
- add back personal expenses run through the business, family wages for work not done, and genuine one time costs;
- deduct anything a new owner would have to pay that you do not, such as a market rent if you own the premises, or a pharmacist to replace you if you are the only one.
The result is the number buyers and lenders price. Our EBITDA normalization guide sets out every accepted and rejected adjustment and how to document them. The short version: every properly documented $10,000 of add backs is worth roughly $40,000 to $60,000 of price, and every undocumented one is worth nothing, because the buyer’s accountant will strike it.
Part two: the multiple
The multiple is not a market statistic; there is no exchange where pharmacy sales are reported. The ranges here are what we see in Canadian transactions, and the provincial baselines in our calculator are our working parameters, reviewed and dated. Three things set where a pharmacy lands within them.
Province. Dispensing fee structures, rebate rules, workforce costs and the size of the buyer pool differ. Alberta’s baseline is the highest (5.5x to 7x); Ontario and BC sit in the middle (5x to 6.5x); the smaller provinces and the territories are lower (4.5x to 6x). The reasons for each are on the valuation page.
Size of the earnings base. Larger pharmacies attract more buyers, including strategic buyers who can pay for integration gains. The calculator shifts the multiple down half a turn for pharmacies under $150,000 of normalized EBITDA and up half a turn above $2,000,000.
Risk. Lease security, owner occupied premises, proximity to a medical clinic, local competition, payer concentration, rebate dependence, whether the owner is the only pharmacist, and the prescription trend each move the multiple by a quarter to three quarters of a turn, capped at one turn up and two turns down. Rent also sits inside EBITDA, so the lease moves the number twice; see how rent changes what a pharmacy is worth.
Three worked examples
All illustrative, and all before inventory.
A small or rural pharmacy. $150,000 of normalized EBITDA, the owner is the only pharmacist, four years left on the lease, one of two pharmacies in town. The size band and the risk factors push the multiple toward the bottom of the range. At 4x the business is worth about $600,000. Add inventory of, say, $120,000 and the price is about $720,000. The buyer pool is small (an individual pharmacist, a regional group, or a grocer with a store nearby), and the deal depends on the buyer’s financing.
A typical suburban pharmacy. $300,000 of normalized EBITDA, two pharmacists on staff, eight years of lease including a renewal, a clinic in the same plaza, no single payer above 25 percent. Mid range in its province. At 5x the business is worth about $1,500,000; with $250,000 of inventory, about $1,750,000. This store draws every buyer type: independents, banner backed buyers, consolidators and, if the location fits, a chain.
A large urban pharmacy. $800,000 of normalized EBITDA, long lease, growing scripts, professional services revenue spread across several pharmacists. Toward the top of its provincial range, and strategic buyers may compete. At 6x the business is worth about $4,800,000; with $400,000 of inventory, about $5,200,000. In Alberta, where the baseline is higher, the same store at the province’s 6.25x midpoint would be about $5,000,000 before inventory.
The gap between the first and third examples is not revenue. It is earnings and risk.
What is not in the number
Inventory is bought separately at cost, counted at closing. In the deals we see it commonly adds $100,000 to $400,000 to a community pharmacy’s price.
The building, if you own it, is a separate asset with its own value, sold or leased to the buyer on its own terms.
Cash and receivables stay with the seller in an asset sale, and are settled in the price in a share sale.
Your own salary is already deducted: normalized EBITDA assumes someone is paid to run the store.
The revenue rule of thumb, and why it does not apply here
Owners sometimes find a figure of 75 to 80 percent of annual revenue quoted as a pharmacy’s value. That rule comes from the United Kingdom, where the funding model and the sale process are different, and it has been repeated by AI search tools answering Canadian questions. It is not how Canadian pharmacies are priced. Two stores with $3 million of revenue can have $150,000 and $450,000 of normalized EBITDA, and they are not worth the same. Canadian buyers price on earnings, and Canadian banks lend on the cash available for debt service, which is derived from earnings, not revenue. Revenue is a cross check at most.
Long term care, compounding and clinic pharmacies
The method is the same; the drivers differ. Long term care pharmacies are priced on contract quality and per bed economics as much as on EBITDA, and their multiples range more widely, roughly 3x to 7x; see the long term care guide. Compounding pharmacies carry their lab and their prescriber relationships as the asset. A pharmacy that shares a building with a medical clinic is valued with the clinic relationship as both the strength and the risk; see the clinic pharmacy guide.
Getting your number
Three levels, in increasing certainty:
- The free calculator. Six inputs, an instant range, no contact details. It applies the provincial baselines, the size band and the risk factors described above. Run it.
- The full assessment. Your real owner compensation, add backs, lease and payer mix, and the lender’s view: what a bank would finance and the equity a buyer needs. Also free, and calculated on the page.
- A professional valuation. A documented report for a sale, a bank or a partner discussion, scoped and quoted per engagement. This is the number you defend to a buyer and their lender.
If you are more than a year from selling, the most valuable thing the number tells you is what to fix. Our seller readiness checklist lists the items that most often cost owners money in due diligence, and the who buys pharmacies in Canada guide explains which buyers will pay the most for which stores.
We are pharmacists, not certified business valuators, and our valuations are professional opinions, not certified valuations. For court, tax or matrimonial purposes you need a Chartered Business Valuator. For planning and negotiating a sale, the number above is the one that matters, and it costs nothing to find out where you stand.